HTN3
Basic information
Region (hg38): 4:70028455-70036538
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 1 | 1 |
Variants in HTN3
This is a list of pathogenic ClinVar variants found in the HTN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-70030780-C-A | not specified | Uncertain significance (Oct 10, 2023) | ||
4-70030790-C-T | not specified | Likely benign (Oct 10, 2023) | ||
4-70033186-G-A | - | no classification for the single variant (-) | ||
4-70033188-G-C | Benign (Dec 31, 2019) | |||
4-70033205-T-A | - | no classification for the single variant (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HTN3 | protein_coding | protein_coding | ENST00000530128 | 4 | 8126 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000411 | 0.235 | 123271 | 167 | 2264 | 125702 | 0.00972 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.469 | 31 | 24.5 | 1.27 | 0.00000104 | 327 |
Missense in Polyphen | 3 | 4.0898 | 0.73353 | 60 | ||
Synonymous | -0.781 | 10 | 7.31 | 1.37 | 3.13e-7 | 76 |
Loss of Function | -0.473 | 6 | 4.87 | 1.23 | 2.69e-7 | 63 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.155 | 0.150 |
Ashkenazi Jewish | 0.0000996 | 0.0000993 |
East Asian | 0.000712 | 0.000707 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000258 | 0.000255 |
Middle Eastern | 0.000712 | 0.000707 |
South Asian | 0.000303 | 0.000294 |
Other | 0.00318 | 0.00310 |
dbNSFP
Source:
- Function
- FUNCTION: Histatins are salivary proteins that are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). In addition, histatins exhibit antibacterial and antifungal activities. His3-(20-43)-peptide (histatin-5) is especially effective against C.albicans and C.neoformans, and inhibits Lys-gingipain and Arg-gingipain (rgpB) from P.gingivalis. In addition, His3-(20-43)-peptide is a potent inhibitor of metalloproteinases MMP2 and MMP9. {ECO:0000269|PubMed:11179305, ECO:0000269|PubMed:8945538}.;
- Pathway
- Salivary secretion - Homo sapiens (human);Antimicrobial peptides;Innate Immune System;Immune System
(Consensus)
Intolerance Scores
- loftool
- 0.741
- rvis_EVS
- 0.95
- rvis_percentile_EVS
- 89.91
Haploinsufficiency Scores
- pHI
- 0.0505
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.102
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- antimicrobial humoral response;biomineral tissue development;killing of cells of other organism;defense response to bacterium;defense response to fungus
- Cellular component
- extracellular region
- Molecular function
- protein binding;metal ion binding